Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

NCT05619770 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Glucocorticoids Toxicity
COVID-19
Infectious Disease
Virus Diseases

Interventions

DRUG: 101-PGC-005

Sponsor

101 Therapeutics